1. Clinical pharmacokinetics and drug–drug interactions of tyrosine-kinase inhibitors in chronic myeloid leukemia: A clinical perspective
   Fang Cheng et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
2. The association of ABC proteins with multidrug resistance in cancer
   Andrezza Viviany Lourenço Marques et al, 2025, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
3. Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells
   Shaocong Wu et al, 2018, Molecular Cancer CrossRef
4. FLT3 Inhibitors as Sensitizing Agents for Cancer Chemotherapy
   Maria R. Baer, 2019, Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy CrossRef
5. Prediction of Novel Drugs for Hepatocellular Carcinoma Based on Multi-Source Random Walk
   Liang Yu et al, 2017, IEEE/ACM Transactions on Computational Biology and Bioinformatics CrossRef
6. Effect of 5,7-dimethoxyflavone on Bcrp1-mediated transport of sorafenib in vitro and in vivo in mice
   SoHyun Bae et al, 2018, European Journal of Pharmaceutical Sciences CrossRef
7. BCR-ABL Inhibitors as Sensitizing Agents for Cancer Chemotherapy
   Qingbin Cui et al, 2019, Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy CrossRef
8. Targeting Chemotherapy Resistance in Glioblastoma Through Modulation of ABC Transporters
   Amanda Tivnan, 2016, Resistance to Targeted Therapies Against Adult Brain Cancers CrossRef
9. Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance
   Nagaraju Anreddy et al, 2014, Molecules CrossRef
10. Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
    Giovanni Luca Beretta et al, 2017, European Journal of Medicinal Chemistry CrossRef
11. The role of drug transporters in the kidney: lessons from tenofovir
    Darren M. Moss et al, 2014, Frontiers in Pharmacology CrossRef
12. Mobocertinib antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells: In vitro and in vivo studies
    Xing-Duo Dong et al, 2024, Cancer Letters CrossRef
13. Lapatinib Antagonizes Multidrug Resistance-Associated Protein 1-Mediated Multidrug Resistance by Inhibiting Its Transport Function
    Shao-lin Ma et al, 2014, Molecular Medicine CrossRef
14. The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
    Rishil J. Kathawala et al, 2015, Drug Resistance Updates CrossRef
15. New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF-7 Cancer Cells
    Angelika Długosz-Pokorska et al, 2023, Biologics: Targets and Therapy CrossRef
16. Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration
    Maria Krchniakova et al, 2020, International Journal of Molecular Sciences CrossRef
17. Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape
    Antonio Solana-Altabella et al, 2023, Expert Review of Clinical Pharmacology CrossRef
18. Quizartinib (AC220) reverses ABCG2-mediated multidrug resistance: In vitro and in vivo studies
    Jun Li et al, 2017, Oncotarget CrossRef
19. ABC Transporter Modulatory Drugs from Marine Sources: A New Approach to Overcome Drug Resistance in Cancer
    Atish Patel et al, 2015, Resistance to Targeted ABC Transporters in Cancer CrossRef
20. Transporter-Mediated Cellular Distribution of Tyrosine Kinase Inhibitors as a Potential Resistance Mechanism in Chronic Myeloid Leukemia
    Noor E. Verhagen et al, 2023, Pharmaceutics CrossRef
21. Mechanistic and Pharmacological Insights into Modulation of ABC Drug Transporters by Tyrosine Kinase Inhibitors
    Suneet Shukla et al, 2016, ABC Transporters - 40 Years on CrossRef
22. Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: a review
    Veerandra Kumar et al, 2022, Molecular and Cellular Biochemistry CrossRef